The refinancing reduces interest costs and extends debt maturity, offering a modest tailwind to free cash flow. Monitor upcoming quarterly filings for updated leverage ratios and any future repricing activity.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 21 $15.71entry
- T+1 · 6mo ago −0.32%α −0.76% · $15.66
- T+5 · 6mo ago +0.25%α −1.34% · $15.75
- T+20 · 5mo ago +0.41%α +0.08% · $15.78
- T+60 · 3mo ago +19.67%α +15.37% · $18.80
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Sotera Health entered into Amendment No. 7 to its First Lien Credit Agreement, refinancing existing term loans with $1.416 billion in new 2026 Refinancing Term Loans at a reduced interest rate spread (25 bps lower) and extending the maturity to May 30, 2031. The transaction modestly lowers annual interest expense and maintains the company's debt capital structure.
Key Financial Metrics
Key Facts
- 2026 Refinancing Term Loans of $1,415,914,725.62 issued to refinance existing term loans in full
- Interest rate spread reduced by 0.25% on term loans (to Adjusted Term SOFR + 2.25%)
- New loans mature May 30, 2031, amortizing at 1.00% per annum
- Soft call premium of 1.00% applies to certain repricing transactions within six months
Financial Impact
Annual interest expense reduction of approximately $3.5 million on $1.416 billion of term loans (0.25% spread reduction)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-232585 |
| Document: d107933d8k.htm | 0001193125-26-232585 |
| Document: 0001193125-26-232585-index-headers.html | 0001193125-26-232585 |
| Document: 0001193125-26-232585-index.html | 0001193125-26-232585 |
| Document: 0001193125-26-232585.txt | 0001193125-26-232585 |
Track record
18 reports on SHC
6 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +16.44% at T+60 after the May 5, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 3, 202613d ago 8-K Neutral 5/10 No price data
- Nov 3, 202613d ago Press Release Bullish 5/10 Entry $16.03 to $16.39 Now $16.25 +1.37% ▲ +2.25% +0.59% vs SPY
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $18.15 to $17.74 Now $16.25 −10.47% ▼ −2.26% −1.78% vs SPY
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $18.13 to $18.10 Now $16.25 −10.37% ▼ −0.17% +0.36% vs SPY
- Oct 9, 20265w ago SC 13G/A Bearish 5/10 Entry $18.15 to $18.21 Now $16.25 +10.47% ▼ −0.33% −0.34% vs SPY
- Aug 14, 202613w ago 8-K Neutral 2/10 Entry $18.89 to $18.80 Now $16.25 −13.98% ▼ −0.48% −0.00% vs SPY
- Aug 9, 202614w ago Institutional Cluster Bullish 4/10 Entry $18.97 to $19.11 Now $16.25 −14.34% ▲ +0.74% +1.06% vs SPY
- Aug 7, 202614w ago 144 Neutral 3/10 Entry $18.86 to $18.97 Now $16.25 −13.84% ▲ +0.58% +0.61% vs SPY
- Aug 6, 202614w ago 8-K Bullish 7/10 Entry $18.91 to $18.86 Now $16.25 −14.07% ▼ −0.26% −0.88% vs SPY
- May 27, 202624w ago 3 Neutral 2/10 Entry $15.75 to $15.64 Now $16.25 +3.17% ▼ −0.70% −0.94% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers